Lobbying registration dated 2026-03-12
Registrant: ANDRE ALBINATI
Client: Kainova Therapeutics Canada
Targeted institutions:
Canadian Institutes of Health Research (CIHR)
Export Development Canada (EDC)
Prime Minister's Office (PMO)
House of Commons
National Defence (DND)
National Research Council (NRC)
Canada Economic Development for Quebec Regions
Innovation, Science and Economic Development Canada (ISED)
Global Affairs Canada (GAC)
Public Health Agency of Canada (PHAC)
Privy Council Office (PCO)
Senate of Canada
Health Canada (HC)
Government funding received:
Institution: Government of France
Amount: 1726862.00
Institution: Investissement Québec
Amount: 12552920.00
Lobbying activity details:
Advance client's goals to secure funding for research, discovery and commercialization of innovative medical products, build ecosystems to increase research and development capacity in the field of life sciences in Canada.